Destiny Pharma (LSE:DEST) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Destiny Pharma's Free Cash Flow for the six months ended in Dec. 2023 was £-3.64 Mil. Destiny Pharma's Revenue for the six months ended in Dec. 2023 was £0.00 Mil. Therefore, Destiny Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Destiny Pharma's current FCF Yield % is -49.49%.

The historical rank and industry rank for Destiny Pharma's FCF Margin % or its related term are showing as below:

LSE:DEST's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.

Destiny Pharma FCF Margin % Historical Data

The historical data trend for Destiny Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma FCF Margin % Chart

Destiny Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Destiny Pharma Semi-Annual Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Destiny Pharma's FCF Margin %

For the Biotechnology subindustry, Destiny Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Destiny Pharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Destiny Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Destiny Pharma's FCF Margin % falls into.

Destiny Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Destiny Pharma's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-5.555	/	0
	=	%

Destiny Pharma's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.639	/	0
	=	%

Destiny Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Destiny Pharma (LSE:DEST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

D89:Germany

Address

Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB

Website

https://www.destinypharma.com

Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines